These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 9850089)
1. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089 [TBL] [Abstract][Full Text] [Related]
2. Thyroid carcinomas in RET/PTC transgenic mice. Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006 [TBL] [Abstract][Full Text] [Related]
3. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638 [TBL] [Abstract][Full Text] [Related]
4. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009 [TBL] [Abstract][Full Text] [Related]
5. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903 [TBL] [Abstract][Full Text] [Related]
6. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma. Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832 [TBL] [Abstract][Full Text] [Related]
7. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261 [TBL] [Abstract][Full Text] [Related]
9. [Rearrangement of the RET gene in papillary thyroid carcinoma]. Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064 [TBL] [Abstract][Full Text] [Related]
10. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Smida J; Salassidis K; Hieber L; Zitzelsberger H; Kellerer AM; Demidchik EP; Negele T; Spelsberg F; Lengfelder E; Werner M; Bauchinger M Int J Cancer; 1999 Jan; 80(1):32-8. PubMed ID: 9935226 [TBL] [Abstract][Full Text] [Related]
12. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas. Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668 [TBL] [Abstract][Full Text] [Related]
13. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma. Rhoden KJ; Johnson C; Brandao G; Howe JG; Smith BR; Tallini G Lab Invest; 2004 Dec; 84(12):1557-70. PubMed ID: 15502856 [TBL] [Abstract][Full Text] [Related]
14. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese. Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154 [TBL] [Abstract][Full Text] [Related]
15. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913 [TBL] [Abstract][Full Text] [Related]
16. RET/PTC rearrangement in thyroid tumors. Nikiforov YE Endocr Pathol; 2002; 13(1):3-16. PubMed ID: 12114746 [TBL] [Abstract][Full Text] [Related]
17. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. Cetta F; Chiappetta G; Melillo RM; Petracci M; Montalto G; Santoro M; Fusco A J Clin Endocrinol Metab; 1998 Mar; 83(3):1003-6. PubMed ID: 9506763 [TBL] [Abstract][Full Text] [Related]
18. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781 [TBL] [Abstract][Full Text] [Related]
19. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225 [TBL] [Abstract][Full Text] [Related]